EXT1 Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 73 pages | ID: E4AB86B0750BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of EXT1 Antibody in Global, including the following market information:

Global EXT1 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global EXT1 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of EXT1 Antibody include R&D Systems, Novus Biologicals, Merck (Sigma-Aldrich), Abcam, AMS Biotechnology, GeneTex and Santa Cruz Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the EXT1 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global EXT1 Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global EXT1 Antibody Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global EXT1 Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global EXT1 Antibody Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global EXT1 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global EXT1 Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies EXT1 Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies EXT1 Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• R&D Systems
• Novus Biologicals
• Merck (Sigma-Aldrich)
• Abcam
• AMS Biotechnology
• GeneTex
• Santa Cruz Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 EXT1 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global EXT1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXT1 ANTIBODY OVERALL MARKET SIZE

2.1 Global EXT1 Antibody Market Size: 2021 VS 2028
2.2 Global EXT1 Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top EXT1 Antibody Players in Global Market
3.2 Top Global EXT1 Antibody Companies Ranked by Revenue
3.3 Global EXT1 Antibody Revenue by Companies
3.4 Top 3 and Top 5 EXT1 Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies EXT1 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 EXT1 Antibody Players in Global Market
  3.6.1 List of Global Tier 1 EXT1 Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 EXT1 Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global EXT1 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global EXT1 Antibody Revenue & Forecasts
  4.2.1 By Type - Global EXT1 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global EXT1 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global EXT1 Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global EXT1 Antibody Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global EXT1 Antibody Revenue & Forecasts
  5.2.1 By Application - Global EXT1 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global EXT1 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global EXT1 Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global EXT1 Antibody Market Size, 2021 & 2028
6.2 By Region - Global EXT1 Antibody Revenue & Forecasts
  6.2.1 By Region - Global EXT1 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global EXT1 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global EXT1 Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America EXT1 Antibody Revenue, 2017-2028
  6.3.2 US EXT1 Antibody Market Size, 2017-2028
  6.3.3 Canada EXT1 Antibody Market Size, 2017-2028
  6.3.4 Mexico EXT1 Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe EXT1 Antibody Revenue, 2017-2028
  6.4.2 Germany EXT1 Antibody Market Size, 2017-2028
  6.4.3 France EXT1 Antibody Market Size, 2017-2028
  6.4.4 U.K. EXT1 Antibody Market Size, 2017-2028
  6.4.5 Italy EXT1 Antibody Market Size, 2017-2028
  6.4.6 Russia EXT1 Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries EXT1 Antibody Market Size, 2017-2028
  6.4.8 Benelux EXT1 Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia EXT1 Antibody Revenue, 2017-2028
  6.5.2 China EXT1 Antibody Market Size, 2017-2028
  6.5.3 Japan EXT1 Antibody Market Size, 2017-2028
  6.5.4 South Korea EXT1 Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia EXT1 Antibody Market Size, 2017-2028
  6.5.6 India EXT1 Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America EXT1 Antibody Revenue, 2017-2028
  6.6.2 Brazil EXT1 Antibody Market Size, 2017-2028
  6.6.3 Argentina EXT1 Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa EXT1 Antibody Revenue, 2017-2028
  6.7.2 Turkey EXT1 Antibody Market Size, 2017-2028
  6.7.3 Israel EXT1 Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia EXT1 Antibody Market Size, 2017-2028
  6.7.5 UAE EXT1 Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 R&D Systems
  7.1.1 R&D Systems Corporate Summary
  7.1.2 R&D Systems Business Overview
  7.1.3 R&D Systems EXT1 Antibody Major Product Offerings
  7.1.4 R&D Systems EXT1 Antibody Revenue in Global Market (2017-2022)
  7.1.5 R&D Systems Key News
7.2 Novus Biologicals
  7.2.1 Novus Biologicals Corporate Summary
  7.2.2 Novus Biologicals Business Overview
  7.2.3 Novus Biologicals EXT1 Antibody Major Product Offerings
  7.2.4 Novus Biologicals EXT1 Antibody Revenue in Global Market (2017-2022)
  7.2.5 Novus Biologicals Key News
7.3 Merck (Sigma-Aldrich)
  7.3.1 Merck (Sigma-Aldrich) Corporate Summary
  7.3.2 Merck (Sigma-Aldrich) Business Overview
  7.3.3 Merck (Sigma-Aldrich) EXT1 Antibody Major Product Offerings
  7.3.4 Merck (Sigma-Aldrich) EXT1 Antibody Revenue in Global Market (2017-2022)
  7.3.5 Merck (Sigma-Aldrich) Key News
7.4 Abcam
  7.4.1 Abcam Corporate Summary
  7.4.2 Abcam Business Overview
  7.4.3 Abcam EXT1 Antibody Major Product Offerings
  7.4.4 Abcam EXT1 Antibody Revenue in Global Market (2017-2022)
  7.4.5 Abcam Key News
7.5 AMS Biotechnology
  7.5.1 AMS Biotechnology Corporate Summary
  7.5.2 AMS Biotechnology Business Overview
  7.5.3 AMS Biotechnology EXT1 Antibody Major Product Offerings
  7.5.4 AMS Biotechnology EXT1 Antibody Revenue in Global Market (2017-2022)
  7.5.5 AMS Biotechnology Key News
7.6 GeneTex
  7.6.1 GeneTex Corporate Summary
  7.6.2 GeneTex Business Overview
  7.6.3 GeneTex EXT1 Antibody Major Product Offerings
  7.6.4 GeneTex EXT1 Antibody Revenue in Global Market (2017-2022)
  7.6.5 GeneTex Key News
7.7 Santa Cruz Biotechnology
  7.7.1 Santa Cruz Biotechnology Corporate Summary
  7.7.2 Santa Cruz Biotechnology Business Overview
  7.7.3 Santa Cruz Biotechnology EXT1 Antibody Major Product Offerings
  7.7.4 Santa Cruz Biotechnology EXT1 Antibody Revenue in Global Market (2017-2022)
  7.7.5 Santa Cruz Biotechnology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. EXT1 Antibody Market Opportunities & Trends in Global Market
Table 2. EXT1 Antibody Market Drivers in Global Market
Table 3. EXT1 Antibody Market Restraints in Global Market
Table 4. Key Players of EXT1 Antibody in Global Market
Table 5. Top EXT1 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global EXT1 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global EXT1 Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies EXT1 Antibody Product Type
Table 9. List of Global Tier 1 EXT1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 EXT1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global EXT1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - EXT1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - EXT1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global EXT1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - EXT1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - EXT1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global EXT1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global EXT1 Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global EXT1 Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America EXT1 Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America EXT1 Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe EXT1 Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe EXT1 Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia EXT1 Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia EXT1 Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America EXT1 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America EXT1 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa EXT1 Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa EXT1 Antibody Revenue, (US$, Mn), 2023-2028
Table 30. R&D Systems Corporate Summary
Table 31. R&D Systems EXT1 Antibody Product Offerings
Table 32. R&D Systems EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 33. Novus Biologicals Corporate Summary
Table 34. Novus Biologicals EXT1 Antibody Product Offerings
Table 35. Novus Biologicals EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Merck (Sigma-Aldrich) Corporate Summary
Table 37. Merck (Sigma-Aldrich) EXT1 Antibody Product Offerings
Table 38. Merck (Sigma-Aldrich) EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Abcam Corporate Summary
Table 40. Abcam EXT1 Antibody Product Offerings
Table 41. Abcam EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 42. AMS Biotechnology Corporate Summary
Table 43. AMS Biotechnology EXT1 Antibody Product Offerings
Table 44. AMS Biotechnology EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 45. GeneTex Corporate Summary
Table 46. GeneTex EXT1 Antibody Product Offerings
Table 47. GeneTex EXT1 Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Santa Cruz Biotechnology Corporate Summary
Table 49. Santa Cruz Biotechnology EXT1 Antibody Product Offerings
Table 50. Santa Cruz Biotechnology EXT1 Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. EXT1 Antibody Segment by Type in 2021
Figure 2. EXT1 Antibody Segment by Application in 2021
Figure 3. Global EXT1 Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global EXT1 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global EXT1 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by EXT1 Antibody Revenue in 2021
Figure 8. By Type - Global EXT1 Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global EXT1 Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global EXT1 Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America EXT1 Antibody Revenue Market Share, 2017-2028
Figure 12. US EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe EXT1 Antibody Revenue Market Share, 2017-2028
Figure 16. Germany EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia EXT1 Antibody Revenue Market Share, 2017-2028
Figure 24. China EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America EXT1 Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa EXT1 Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE EXT1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. R&D Systems EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novus Biologicals EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck (Sigma-Aldrich) EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abcam EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AMS Biotechnology EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GeneTex EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Santa Cruz Biotechnology EXT1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)